Abstract Body

A complex series of events starting from enterocytes modifications, mucosal immune dysfunction, damage to the intestinal epithelial barrier, microbial translocation, and chronic systemic immune activation, contribute to HIV disease progression. This study aimed to verify whether the modulation of microbiota plays a role in restoring the intestinal barrier integrity focusing on cellular morphology, cellular apoptosis machinery and mitochondrial restoring.

10 Caucasian cART-treated HIV-1+ patients and 10 healthy age and gender matched controls were recruited at the Department of Public Health and Infectious Diseases, Sapienza University of Rome (Italy). HIV+ participants received for six months two sachets, each containing 450 × 109 billion bacteria, twice a day of Vivomixx®. All patients underwent to pancolonoscopy and blood sampling before (T0) and after 6 months of probiotic supplementation (T6). Cellular morphology, cellular apoptosis machinery and mitochondrial restoring were analyzed in mucosal biopsies taken from different colonic tracts of intestine at T0 and T6.

After the probiotic administration, sections of intestinal mucosa showed an improvement of epithelial integrity and a reduction of diffuse interstitial inflammatory infiltrate. The rate of enterocytes, undergoing apoptosis both in epithelium and intestinal crypts, was significantly reduced at T6 (p=0.04). Mitochondria number and size differed from the 2 groups of patients (p>0.05): samples taken at T6 showed significant increased number of larger mitochondria and the levels of these organelles were similar to healthy samples (p>0.05).Ultrastructural morphological data regarding mitochondria were confirmed by mt-DNA evaluation at T6 that indicated an increase concentration of mitochondria in all tested patients (p<0.005) and a similar trend for CYCC concentration (p<0.005), with substantial reduction of HSP60 and 70 m-RNA expression in mucosal biopsies (p<0.005). LPS and cCK18 plasma levels significantly decreased at T6 (p<0.05).

The modulation of intestinal microbiota ameliorates histopathologic alterations characterizing HIV enteropathy, reducing inflammatory cells infiltration,villous blunting and widening, vacuolated enterocytes, crypt hyperplasia. All these data are in accord with a decrease in LPS and cCK18 plasma levels after probiotic supplementation, respect to levels that were observed at baseline.